Your browser doesn't support javascript.
loading
LncRNA MDRL Mitigates Atherosclerosis through miR-361/SQSTM1/NLRP3 Signaling.
You, Ling; Zheng, Yanjie; Yang, Jing; Hou, Qian; Wang, Lianxia; Zhang, Yan; Zhao, Chunxia; Xie, Ruiqin.
Afiliação
  • You L; Division of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Zheng Y; Division of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Yang J; Division of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Hou Q; Division of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Wang L; Division of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Zhang Y; Division of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Zhao C; Institute of Hypertension and Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Xie R; Division of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Mediators Inflamm ; 2022: 5463505, 2022.
Article em En | MEDLINE | ID: mdl-36186576
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Aterosclerose / Placa Aterosclerótica / RNA Longo não Codificante Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Aterosclerose / Placa Aterosclerótica / RNA Longo não Codificante Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article